|
Overview |
Product information |
Accredo services |
Contact team
Cimzia is a tumor necrosis factor (TNF) blocker indicated for:
-
Reducing signs and symptoms of Crohn’s disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy
-
Treatment of adults with moderately to severely active rheumatoid arthritis1
For more information, please visit Cimzia.com, or download the medication guide for patients:
1. Cimzia® (certolizumab pegol) [package insert]. Smyrna, GA: UCB, Inc.; 2009.
Cimzia is a registered trademark of UCB, Inc.
| 
